Teriflunomide (Aubagio®) for the treatment of multiple sclerosisBAR-OR, Amit.Experimental neurology (Print). 2014, Vol 262, pp 57-65, issn 0014-4886, 9 p., aArticle

Semiblind Turbo Equalization Scheme for LTE Uplink ReceiverKUTZ, Gideon; BAR-OR, Amit; RAPHAELI, Dan et al.IEEE transactions on vehicular technology. 2012, Vol 61, Num 9, pp 4199-4205, issn 0018-9545, 7 p.Article

Do myelin-directed antibodies predict multiple sclerosis?ANTEL, Jack P; BAR-OR, Amit.The New England journal of medicine. 2003, Vol 349, Num 2, pp 107-109, issn 0028-4793, 3 p.Article

Treatment of multiple sclerosis with Anti-CD20 antibodiesBARUN, Barbara; BAR-OR, Amit.Clinical immunology (Orlando, Fla. Print). 2012, Vol 142, Num 1, pp 31-37, issn 1521-6616, 7 p.Article

Targeting Progressive Neuroaxonal Injury: Lessons from Multiple SclerosisBAR-OR, Amit; RIECKMANN, Peter; TRABOULSEE, Anthony et al.CNS drugs. 2011, Vol 25, Num 9, pp 783-799, issn 1172-7047, 17 p.Article

Distinct Properties of Circulating CD8⁺ T Cells in FTY720-Treated Patients With Multiple SclerosisJOHNSON, Trina A; LAPIERRE, Yves; BAR-OR, Amit et al.Archives of neurology (Chicago). 2010, Vol 67, Num 12, pp 1449-1455, issn 0003-9942, 7 p.Article

Teriflunomide and Its Mechanism of Action in Multiple SclerosisBAR-OR, Amit; PACHNER, Andrew; MENGUY-VACHERON, Francoise et al.Drugs (Basel). 2014, Vol 74, Num 6, pp 659-674, issn 0012-6667, 16 p.Article

What do we know about the mechanism of action of disease-modifying treatments in MS?HARTUNG, Hans-Peter; BAR-OR, Amit; ZOUKOS, Yannis et al.Journal of neurology. Supplement. 2004, Vol 251, Num 5, pp V.12-V.29, issn 0939-1517Article

Patient and community preferences for treatments and health states in multiple sclerosisPROSSER, Lisa A; KUNTZ, Karen M; BAR-OR, Amit et al.Multiple sclerosis. 2003, Vol 9, Num 3, pp 311-319, issn 1352-4585, 9 p.Article

Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosisHENAULT, David; GALLEGUILLOS, Lorna; MOORE, Craig et al.Neurology. 2013, Vol 81, Num 20, pp 1768-1772, issn 0028-3878, 5 p.Article

Laquinimod in multiple sclerosisGIACOMINI, Paul S; BAR-OR, Amit.Clinical immunology (Orlando, Fla. Print). 2012, Vol 142, Num 1, pp 38-43, issn 1521-6616, 6 p.Article

Myelin regulates immune cell adhesion and motilityPOOL, Madeline; NIINO, Masaaki; RAMBALDI, Isabel et al.Experimental neurology (Print). 2009, Vol 217, Num 2, pp 371-377, issn 0014-4886, 7 p.Article

Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patientsHO JIN KIM; BIERNACKI, Katarzyna; PRAT, Alexandre et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 111, Num 1, pp 38-46, issn 1521-6616, 9 p.Article

The neuroimmunology of multiple sclerosis: Possible roles of T and B lymphocytes in immunopathogenesisO'CONNOR, Kevin C; BAR-OR, Amit; HAFLER, David A et al.Journal of clinical immunology. 2001, Vol 21, Num 2, pp 81-92, issn 0271-9142Conference Paper

Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptaseKILPATRICK, Lynette M; HARRIS, Roger L; OWEN, Kate A et al.Blood. 2006, Vol 108, Num 8, pp 2616-2623, issn 0006-4971, 8 p.Article

Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseasesANTONY, Joseph M; IZAD, Maryam; BAR-OR, Amit et al.AIDS research and human retroviruses. 2006, Vol 22, Num 12, pp 1253-1259, issn 0889-2229, 7 p.Article

Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MSZASTEPA, Evelyn; FITZ-GERALD, Leslie; HALLETT, Michael et al.Neurology. 2014, Vol 82, Num 8, pp 681-690, issn 0028-3878, 10 p.Article

Epstein-Barr virus in oral shedding of children with multiple sclerosisYEA, Carmen; TELLIER, Raymond; CHONG, Patrick et al.Neurology. 2013, Vol 81, Num 16, pp 1392-1399, issn 0028-3878, 8 p.Article

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MSARNOLD, Douglas L; CAMPAGNOLO, Denise; PANITCH, Hillel et al.Journal of neurology. 2008, Vol 255, Num 10, pp 1473-1478, issn 0340-5354, 6 p.Article

Reconstitution of circulating lymphocyte counts in FTY720-treated MS patientsJOHNSON, Trina A; SHAMES, Igor; KEEZER, Mark et al.Clinical immunology (Orlando, Fla. Print). 2010, Vol 137, Num 1, pp 15-20, issn 1521-6616, 6 p.Article

Neuromvelitis optica with hypothalamic involvementPOPPE, Alexandre Y; LAPIERRE, Yves; MELANCON, Denis et al.Multiple sclerosis. 2005, Vol 11, Num 5, pp 617-621, issn 1352-4585, 5 p.Article

Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous systemSHAPIRO, Aaron M; JACK, Carolyn S; LAPIERRE, Yves et al.Archives of neurology (Chicago). 2006, Vol 63, Num 9, pp 1296-1299, issn 0003-9942, 4 p.Article

Implication of Perturbed Axoglial Apparatus in Early Pediatric Multiple SclerosisAJIT SINGH DHAUNCHAK; BECKER, Christopher; SCHULMAN, Howard et al.Annals of neurology. 2012, Vol 71, Num 5, pp 601-613, issn 0364-5134, 13 p.Article

Rituximab in Relapsing-Remitting Multiple Sclerosis : A 72-Week, Open-Label, Phase I TrialBAR-OR, Amit; CALABRESI, Peter A. J; SARKAR, Neena et al.Annals of neurology. 2008, Vol 63, Num 3, pp 395-400, issn 0364-5134, 6 p.Article

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis : implications for CNS immunityWIENDL, Heinz; FEGER, Ute; KIESEIER, Bernd C et al.Brain. 2005, Vol 128, pp 2689-2704, issn 0006-8950, 16 p., 11Article